Are Syrian refugee breast cancer patients diagnosed at advanced stage and do they have treatment delays?

[ X ]

Tarih

2023

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Future Medicine Ltd

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Aim: To compare the clinicopathological features and time to reach treatment of patients with breast cancer among Syrian refugees (SRs) and Turkish citizens (TCs). Methods: Retrospective data from 2014 to 2021 were extracted from the hospital database. Student's t-test, Mann-Whitney U test and chi 2 test were used to compare the two groups. Results: Data of 88 SR and 402 TC patients were analyzed. The mean age was 45 years for SRs and 50 years for TCs. Breast cancer subtypes were similar in both groups. The de novo metastatic ratio was 23% in SRs and 21.3% in TCs and the time to reach treatment was similar between the two groups. Conclusion: Provided the absence of any obstacle in the healthcare system, SRs are diagnosed and treated like the citizens of their host nation. Tweetable abstractPatients with breast cancer among Syrian refugees are younger but are not diagnosed and treated later than Turkish citizens. #Syrian #refugees #TreatmentDelay #BreastCancer

Açıklama

Anahtar Kelimeler

Breast Cancer, Neoadjuvant, Stage, Syrian Refugees, Treatment Delay

Kaynak

Future Oncology

WoS Q Değeri

N/A

Scopus Q Değeri

Q2

Cilt

19

Sayı

14

Künye